Question: why is nktr stock down?
Answer: Nektar Therapeutics plummets 40% after disclosing a quality-control issue with a key cancer therapy (NKTR) Shares of Nektar Therapeutics crashed 39% on Friday morning after the biopharmaceutical company divulged a quality-control issue with a key cancer therapy.